← Browse by Condition
Medical Condition
recurrent breast carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06704659
Recruiting
Study on Recurrent Breast Cancer and Repeated Radiation Therapy
Enrollment
60 pts
Location
Finland
Sponsor
Turku University Hospital